AtriCure, Inc. (ATRC) Tops Q3 EPS by 2c, Offers Guidance
AtriCure, Inc. (NASDAQ: ATRC) reported Q3 EPS of ($0.13), $0.02 better than the analyst ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
